Page last updated: 2024-09-03

20-hydroxy-5,8,11,14-eicosatetraenoic acid and Renal Insufficiency, Chronic

20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Renal Insufficiency, Chronic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Hasegawa, Y; Hirata, T; Inatani, S; Kojima, N; Koretsune, H; Ohara, H; Takahashi, T1
Afshinnia, F; Byun, J; Chen, J; Deo, R; Feldman, HI; Fischer, MJ; Hamm, L; Michailidis, G; Miller, ER; Pennathur, S; Rhee, EP; Sharma, K; Wernisch, S; Zeng, L1
Barola, C; Bartolini, D; Galarini, R; Galli, F; Gioiello, A; Giusepponi, D; Libetta, C; Moretti, S; Saluti, G; Torquato, P1
Barden, AE; Beilin, LJ; Burke, V; Irish, AB; Mas, E; Mori, TA; Puddey, IB; Watts, GF1
Grassi, G; Mallamaci, F; Zoccali, C1

Trials

1 trial(s) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Renal Insufficiency, Chronic

ArticleYear
n-3 fatty acids reduce plasma 20-hydroxyeicosatetraenoic acid and blood pressure in patients with chronic kidney disease.
    Journal of hypertension, 2015, Volume: 33, Issue:9

    Topics: Adult; Aged; Blood Pressure; Dietary Supplements; Double-Blind Method; F2-Isoprostanes; Fatty Acids, Omega-3; Female; Humans; Hydroxyeicosatetraenoic Acids; Male; Middle Aged; Renal Insufficiency, Chronic; Treatment Outcome

2015

Other Studies

4 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Renal Insufficiency, Chronic

ArticleYear
Renoprotective Effect of TP0472993, a Novel and Selective 20-Hydroxyeicosatetraenoic Acid Synthesis Inhibitor, in Mouse Models of Renal Fibrosis.
    The Journal of pharmacology and experimental therapeutics, 2023, Volume: 386, Issue:1

    Topics: Animals; Disease Models, Animal; Fibrosis; Kidney; Kidney Diseases; Mice; Mice, Inbred C57BL; Nephritis; Renal Insufficiency, Chronic; Ureteral Obstruction

2023
Elevated lipoxygenase and cytochrome P450 products predict progression of chronic kidney disease.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2020, 02-01, Volume: 35, Issue:2

    Topics: Case-Control Studies; Cohort Studies; Cytochrome P-450 Enzyme System; Disease Progression; Female; Humans; Hydroxyeicosatetraenoic Acids; Kidney Failure, Chronic; Lipoxygenase; Male; Middle Aged; Renal Insufficiency, Chronic

2020
LC-MS/MS assay for the simultaneous determination of tocopherols, polyunsaturated fatty acids and their metabolites in human plasma and serum.
    Free radical biology & medicine, 2019, 11-20, Volume: 144

    Topics: Adult; Arachidonic Acid; Case-Control Studies; Chromatography, Liquid; Eicosanoids; Fatty Acids, Unsaturated; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Male; Middle Aged; Renal Insufficiency, Chronic; Tandem Mass Spectrometry; Vitamin E

2019
20-Hydroxyeicosatetraenoic acid, a far-reaching autacoid in chronic kidney disease: hypertension and beyond.
    Journal of hypertension, 2015, Volume: 33, Issue:9

    Topics: Humans; Hydroxyeicosatetraenoic Acids; Hypertension; Renal Insufficiency, Chronic

2015